|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received on April 7, 2004
Accepted on September 13, 2004
Hemostasis and Thrombosis |
1 Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Germany, and These authors contributed equally to this work
2 Institute of Transfusion Medicine and Immunology, Red Cross Blood Service of Baden-Württemberg-Hessen, University of Heidelberg, Faculty of Clinical Medicine, Mannheim, Germany, and These authors contributed equally to this work
3 Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Germany
4 Department of Haemostaseology, Clinical Immunology and Transfusion Medicine, Kerckhoff-Klinik, Bad Nauheim, Germany
5 Institute of Transfusion Medicine and Immunology, Red Cross Blood Service of Baden-Württemberg-Hessen, University of Heidelberg, Faculty of Clinical Medicine, Mannheim, Germany
Background: Genetic analysis of platelet mRNA may facilitate the diagnosis of disorders affecting the megakaryocytic-platelet lineage. Its use, however, is limited by the exceptionally small yield of platelet mRNA and the risk of leukocyte contamination during platelet preparation.
Methods: We depleted platelet suspensions of leukocytes by filtration and used a PCR-based RNA amplification step [switching mechanism at the 5' end of RNA templates (SMART)]. We tested the reliability and precision of the RNA amplification procedure by use of real-time PCR to measure quantities of specific transcripts: von Willebrand factor (vWF), A-subunit of coagulation factor XIII (F13A), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Microarray analysis was performed on platelet RNA with and without amplification.
Results: Microgram quantities of platelet-specific cDNAs were produced from as little as 50 ng of total platelet RNA or 40 mL of whole blood. At cycle numbers <16, amplification of all transcripts tested was exponential with slightly more efficient amplification of low-abundance transcripts. Expression profiling of 9850 genes gave identical results for 9815 genes (1576 positive/8239 negative). Eight transcripts failed to be amplified by the SMART procedure. Expression of vWF, F13A, and GAPDH transcripts showed only minor day-to-day variations in three healthy individuals.
Conclusion: The proposed protocol makes extremely small amounts of platelet RNA available for gene expression analysis in single patients.
The following articles in journals at HighWire Press have cited this article:
![]() |
D. V. Gnatenko, P. L. Perrotta, and W. F. Bahou Proteomic approaches to dissect platelet function: half the story Blood, December 15, 2006; 108(13): 3983 - 3991. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wilhelm, J. P. Muyal, J. Best, G. Kwapiszewska, M. M. Stein, W. Seeger, R. M. Bohle, and L. Fink Systematic Comparison of the T7-IVT and SMART-Based RNA Preamplification Techniques for DNA Microarray Experiments Clin. Chem., June 1, 2006; 52(6): 1161 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhou, R. V. Abruzzese, I. Polejaeva, S. Davis, S. Davis, and W. Ji Amplification of Nanogram Amounts of Total RNA by the SMART-Based PCR Method for High-Density Oligonucleotide Microarrays Clin. Chem., December 1, 2005; 51(12): 2354 - 2356. [Full Text] [PDF] |
||||
![]() |
N. Rolf, R. Knoefler, M. Suttorp, H. Kluter, and P. Bugert Optimized Procedure for Platelet RNA Profiling from Blood Samples with Limited Platelet Numbers Clin. Chem., June 1, 2005; 51(6): 1078 - 1080. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |